Tomohiro Ohno

Name	Tomohiro Ohno
URL
Affiliation	Chiba University
Section	Hospital
Job title	医員
Degree	Bachelor(School of Medicine, Chiba University), Doctor(Graduate School of Medical and Pharmaceutical Sciences, Chiba University)
Research funding number	60918788
J-Global ID	202101014996376090

Research Interests

FoxO1 ,Akt ,脂肪細胞 ,インスリン作用 ,内分泌学 ,糖尿病

Research Areas

Life sciences / Metabolism and endocrinology / 糖尿病

Research History

Apr 2017

Today

千葉大学医学部附属病院糖尿病・代謝・内分泌内科医員

Apr 2016

Mar 2017

千葉市立青葉病院内科後期研修医

Apr 2015

Mar 2016

千葉大学医学部附属病院糖尿病・代謝・内分泌内科シニアレジデント

Apr 2013

Mar 2015

Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology

Education

Apr 2017

Mar 2021

Chiba University Graduate School of Medical and Pharmaceutical Sciences

Apr 2007

Mar 2013

Chiba University School of Medicine

Papers

Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events.

Yoshiro Maezawa Yusuke Endo Satomi Kono Tomohiro Ohno Yuumi Nakamura Naoya Teramoto Ayano Yamaguchi Kazuto Aono Takuya Minamizuka Hisaya Kato Takahiro Ishikawa Masaya Koshizaka Minoru Takemoto Toshinori Nakayama Koutaro Yokote

Journal of diabetes investigation 14(9) 1136-1139 Jun 2023

Psoriasis is a chronic inflammatory skin disease that is associated with obesity and myocardial infarction. Obesity-induced changes in lipid metabolism promote T helper 17 (Th17) cell differentiation, which in turn promotes chronic inflammation. T...

Correction of Hypercortisolemia with an Improved Cognitive Function and Muscle Mass after Transsphenoidal Surgery in an Older Patient with Cushing's Disease: A Case Report.

Ryo Terayama Takahiro Ishikawa Kazuki Ishiwata Ai Sato Takuya Minamizuka Tomohiro Ohno Satomi Kono Masashi Yamamoto Hidetaka Yokoh Hidekazu Nagano Masaya Koshizaka Sawako Suzuki Hisashi Koide Yoshiro Maezawa Koutaro Yokote

Internal medicine (Tokyo, Japan) 61(22) 3391-3399 Apr 2022

Cushing's disease causes numerous metabolic disorders, cognitive decline, and sarcopenia, leading to deterioration of the general health in older individuals. Cushing's disease can be treated with transsphenoidal surgery, but thus far, surgery has...

Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats

Kenji Takeda Hiraku Ono Ko Ishikawa Tomohiro Ohno Jin Kumagai Hidetoshi Ochiai Ai Matumoto Hidetaka Yokoh Yoshiro Maezawa Koutaro Yokote

BMJ Open Diabetes Research & Care 9(1) e002104-e002104 Apr 2021

Introduction

Sodium glucose cotransporter-2 (SGLT2) inhibitors are widely used for diabetes treatment. Although SGLT2 inhibitors have been clinically observed to increase food intake, roles or even the presence of SGLT2 in the central nervous sys...